SPPI - Spectrum Pharmaceuticals Inc. (SPPI) CEO Thomas Riga on Q1 2022 Results - Earnings Call Transcript
Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2022 Results Conference Call May 12, 2022 04:30 PM ET Company Participants Michael Grabow - Senior Vice President of Corporate Strategy and Operations Thomas Riga - President and CEO Francois Lebel - Chief Medical Officer Conference Call Participants Maury Raycroft - Jefferies Edward White - H.C. Wainwright Mayank Mamtani - B. Riley Securities Presentation Operator Thank you for standing by. And welcome to the Spectrum Pharmaceuticals First Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to Mr. Michael Grabow, Senior Vice President of Corporate Strategy and Operations. Please go ahead. Michael Grabow Thank you, operator. Good afternoon to everyone. Thank you for joining us today for Spectrum Pharmaceuticals first quarter 2022 financial results conference call. Our first quarter
For further details see:
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Thomas Riga on Q1 2022 Results - Earnings Call Transcript